BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 1447748)

  • 21. Investigation relevant to the conformation of the 17-membered Pt(d(GpG)) macrocyclic ring formed by Pt anticancer drugs with DNA: Pt complexes with a Goldilocks carrier ligand.
    Maheshwari V; Marzilli PA; Marzilli LG
    Inorg Chem; 2011 Jul; 50(14):6626-36. PubMed ID: 21667929
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Investigation of the configurational and conformational influences on the hormonal activity of 1,2-bis(2,6-dichloro-4-hydroxyphenyl)ethylenediamines and of their platinum(II) complexes. 1. Synthesis, estradiol receptor affinity, and estrogenic activity of diastereomeric [N-alkyl- and N,N'-dialkyl-1,2- bis(2,6-dichloro-4-hydroxyphenyl)ethylenediamine]dichloroplatinum(II) complexes.
    Gust R; Niebler K; Schönenberger H
    J Med Chem; 1995 Jun; 38(12):2070-9. PubMed ID: 7783138
    [TBL] [Abstract][Full Text] [Related]  

  • 23. cis-[PtCl2(4,7-H-5-methyl-7-oxo[1,2,4]triazolo[1,5-a]pyrimidine)2]: a sterically restrictive new cisplatin analogue. Reaction kinetics with model nucleobases, DNA interaction studies, antitumor activity, and structure-activity relationships.
    Navarro JA; Salas JM; Romero MA; Vilaplana R; Gonzalez-Vílchez F; Faure R
    J Med Chem; 1998 Jan; 41(3):332-8. PubMed ID: 9464364
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interaction of 11 cisplatin analogues with DNA: characteristic pattern of damage with monofunctional analogues.
    Murray V; Whittaker J; Temple MD; McFadyen WD
    Biochim Biophys Acta; 1997 Nov; 1354(3):261-71. PubMed ID: 9427535
    [TBL] [Abstract][Full Text] [Related]  

  • 25. cis-diamineplatinum (II) complexes containing phosphono carboxylate ligands as antitumor agents.
    Hollis LS; Miller AV; Amundsen AR; Schurig JE; Stern EW
    J Med Chem; 1990 Jan; 33(1):105-11. PubMed ID: 2296007
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mammary tumor inhibiting [1,2-bis(2,6-dihalo-3-hydroxyphenyl)ethylenediamine]platinum(II) complexes, III: Relationship between structure and estrogenic activity of the diamine ligands, their sulfatoplatinum(II) and diiodoplatinum(II) complexes.
    Gust R; Schönenberger H
    Arch Pharm (Weinheim); 1993 Jul; 326(7):405-13. PubMed ID: 8357303
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Unusual reactivity of cisplatin analogs that bear o-phenylenediamine ligands: insights for the design of more effective cytotoxic agents.
    Köckerbauer R; Bednarski PJ
    J Inorg Biochem; 1996 Jun; 62(4):281-98. PubMed ID: 8676105
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cisplatin mediates selective downstream hydrolytic cleavage of Met-(Gly)(n)-His segments (n=1,2) in methionine- and histidine-containing peptides: the role of ammine loss trans to the initial Pt-S(Met) anchor in facilitating amide hydrolysis.
    Hohage O; Sheldrick WS
    J Inorg Biochem; 2006 Sep; 100(9):1506-13. PubMed ID: 16806482
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reaction of polynuclear platinum antitumor compounds with reduced glutathione studied by multinuclear (1H, 1H-15N gradient heteronuclear single-quantum coherence, and 195Pt) NMR spectroscopy.
    Oehlsen ME; Qu Y; Farrell N
    Inorg Chem; 2003 Sep; 42(18):5498-506. PubMed ID: 12950196
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of amine ligand bulk on the interaction of methionine with platinum(II) diamine complexes.
    Williams KM; Rowan C; Mitchell J
    Inorg Chem; 2004 Feb; 43(3):1190-6. PubMed ID: 14753844
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Importance of platinum(II)-assisted platinum(IV) substitution for the oxidation of guanosine derivatives by platinum(IV) complexes.
    Choi S; Vastag L; Larrabee YC; Personick ML; Schaberg KB; Fowler BJ; Sandwick RK; Rawji G
    Inorg Chem; 2008 Feb; 47(4):1352-60. PubMed ID: 18220340
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cytotoxic activity and cellular processing in human ovarian carcinoma cell lines of a new platinum(II) compound containing a fluorescent substituted propylene diamine ligand.
    Marqués-Gallego P; den Dulk H; Brouwer J; Tanase S; Mutikainen I; Turpeinen U; Reedijk J
    Biochem Pharmacol; 2009 Aug; 78(4):365-73. PubMed ID: 19413998
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reversible and irreversible interactions of a cisplatin analog bearing a 1,2-diphenylethylenediamine ligand with plasma and plasma proteins in vitro.
    Bednarski PJ; Kratochwil NA; Otto AM
    Drug Metab Dispos; 1994; 22(3):419-27. PubMed ID: 7520852
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Discrepancy between cytotoxicity, platinum accumulation, and DNA platination in MCF-7 breast cancer cells treated with diaqua (1,2-diphenylethylenediamine) platinum (II) sulfates and cisplatin.
    Lux F; Hollstein M; Reile H; Bernhardt G; Schönenberger H
    Biol Trace Elem Res; 1996; 53(1-3):113-28. PubMed ID: 8862742
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The reaction of platinum(II) complexes with DNA. Kinetics of intrastrand crosslink formation in vitro.
    Bernges F; Holler E
    Nucleic Acids Res; 1991 Apr; 19(7):1483-9. PubMed ID: 2027756
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis, structure, and reactivity of monofunctional platinum(II) and palladium(II) complexes containing the sterically hindered ligand 6-(methylpyridin-2-yl)acetate.
    Ma Y; Day CS; Bierbach U
    J Inorg Biochem; 2005 Oct; 99(10):2013-23. PubMed ID: 16087242
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intracellular biotransformation of platinum compounds with the 1,2-diaminocyclohexane carrier ligand in the L1210 cell line.
    Mauldin SK; Gibbons G; Wyrick SD; Chaney SG
    Cancer Res; 1988 Sep; 48(18):5136-44. PubMed ID: 3409241
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of carrier ligand in platinum resistance of human carcinoma cell lines.
    Schmidt W; Chaney SG
    Cancer Res; 1993 Feb; 53(4):799-805. PubMed ID: 8428361
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vitro formation of DNA adducts by cisplatin, lobaplatin and oxaliplatin in calf thymus DNA in solution and in cultured human cells.
    Saris CP; van de Vaart PJ; Rietbroek RC; Blommaert FA
    Carcinogenesis; 1996 Dec; 17(12):2763-9. PubMed ID: 9006117
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Thiolate bridging and metal exchange in adducts of a zinc finger model and Pt(II) complexes: biomimetic studies of protein/Pt/DNA interactions.
    Almaraz E; de Paula QA; Liu Q; Reibenspies JH; Darensbourg MY; Farrell NP
    J Am Chem Soc; 2008 May; 130(19):6272-80. PubMed ID: 18422317
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.